Nuclivision
Private Company
Funding information not available
Overview
Nuclivision is a private, commercial-stage software company focused on optimizing nuclear medicine imaging. The company's core technology, NUCLARITY®, uses advanced algorithms to enhance PET scan data, allowing for reduced radioactive tracer doses or shorter scan times without compromising image quality. This addresses critical industry challenges of patient wait times, radiation safety, and operational costs. Backed by notable investors and a strong advisory board, Nuclivision is positioned to scale its impact in the diagnostic imaging market.
Technology Platform
Proprietary software platform using machine learning and computer vision algorithms to enhance PET imaging data, enabling reduced radiotracer dose or shorter scan times while maintaining diagnostic image quality.
Opportunities
Risk Factors
Competitive Landscape
Nuclivision competes in the emerging space of AI software for medical imaging enhancement. Potential competitors include large scanner OEMs (GE, Siemens, Philips) who may develop similar features in-house, and other AI-focused startups. Nuclivision's differentiation lies in its specialized focus on nuclear medicine PET data and its strong clinical advisory network.